Nurix Therapeutics (NRIX) Net Income towards Common Stockholders (2019 - 2026)
Nurix Therapeutics (NRIX) posted Net Income towards Common Stockholders of $549.81 million for fiscal Q3 2026 (quarter ended Aug 31, 2026), compared with -$86.42 million a year earlier.
Powered by 
Analysis
Nurix Therapeutics (NRIX) Net Income towards Common Stockholders (2019 - 2026) Analysis & Trends
For the trailing twelve months through Aug 31, 2026, Net Income towards Common Stockholders at Nurix Therapeutics was $294.88 million; for FY2025 (ended Nov 30, 2025), it was -$264.46 million.
- In prior fiscal years, Nurix Therapeutics' Net Income towards Common Stockholders was -$193.57 million in FY2024, -$143.95 million in FY2023, -$180.36 million in FY2022 and -$117.19 million in FY2021.
- The fiscal Q3 2026 figure stands as the highest quarterly Net Income towards Common Stockholders in data going back to fiscal Q3 2019.
- According to Business Quant data, Net Income towards Common Stockholders for the three prior fiscal quarters was -$89.54 million (Q2 2026), -$87.17 million (Q1 2026) and -$78.22 million (Q4 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 6.45 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 210.00 Mn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 4.22 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 5.07 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 3.12 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 3.86 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 2.43 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 3.24 Bn |
| 10 | Nurix Therapeutics | 1.73 Bn | -891.35 Mn | - | 549.81 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Aug 31, 2026 | 549.81 Mn |
| May 31, 2026 | -89.54 Mn |
| Feb 28, 2026 | -87.17 Mn |
| Nov 30, 2025 | -78.22 Mn |
| Aug 31, 2025 | -86.42 Mn |
| May 31, 2025 | -43.46 Mn |
| Feb 28, 2025 | -56.35 Mn |
| Nov 30, 2024 | -58.55 Mn |
| Aug 31, 2024 | -48.96 Mn |
| May 31, 2024 | -44.55 Mn |
| Feb 29, 2024 | -41.52 Mn |
| Nov 30, 2023 | -41.96 Mn |
| Aug 31, 2023 | -36.98 Mn |
| May 31, 2023 | -24.28 Mn |
| Feb 28, 2023 | -40.73 Mn |
| Nov 30, 2022 | -46.72 Mn |
| Aug 31, 2022 | -45.71 Mn |
| May 31, 2022 | -45.40 Mn |
| Feb 28, 2022 | -42.53 Mn |
| Nov 30, 2021 | -37.70 Mn |
API Access
Nurix Therapeutics Net Income towards Common Stockholders API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=net-income-towards-common-stockholders&ticker=NRIX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "net-income-towards-common-stockholders", "ticker": "NRIX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=net-income-towards-common-stockholders&ticker=NRIX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();